Cromos Pharma, where the patients are

Global News

Annalisa Jenkins named IIR Partnerships’ Woman of the Year

Tuesday, April 1, 2014 01:43 PM

Annalisa Jenkins, former executive vice president, head of global R&D at Merck Serono, has been named IIR Partnerships’ Woman of the Year.

More... »

CRF Health eCOA webinar series

The CenterWatch Monthly, April 2014

Tuesday, April 1, 2014 09:06 AM

Make way for mobile health in clinical trials

More... »


Icon acquires Aptiv Solutions to strengthen adaptive design capabilities

Monday, March 31, 2014 03:04 PM

Seeking to enhance its capabilities in the design and execution of portfolio-wide adaptive clinical trials for pharmaceutical, biotech and medical device companies, Icon has agreed to acquire Aptiv Solutions, a global services company focused on enhancing clinical trial decision-making, for $143.5 million in cash.

More... »

AstraZeneca, Shenzhen University Health Science Center to collaborate

Monday, March 31, 2014 01:37 PM

AstraZeneca has announced a research collaboration with Shenzhen University Health Science Center. The partners will undertake preclinical research focused on chronic kidney disease (CKD), which represents a large and growing unmet medical need in China.

More... »

Covance expands global biologics capabilities

Monday, March 31, 2014 01:36 PM

Covance is expanding its global bioanalytical footprint and adding scientific leaders to its biologics team. It is expanding its large-molecule bioanalytical space co-located with its central laboratory facility in Indianapolis.

More... »

Janssen expands global cardiovascular research program with three new studies

Monday, March 31, 2014 12:56 PM

Janssen R&D is adding three new clinical trials to its EXPLORER global cardiovascular research program for XARELTO (rivaroxaban), a broadly indicated oral Factor Xa inhibitor. The additional trials will evaluate rivaroxaban for the treatment or prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE) in pediatric and other patient populations, including those at risk for DVT or PE due to a concurrent medical illness. The new studies will include more than 11,000 patients in over 30 countries.

More... »

Report: Strategic partnerships most effective biopharmaceutical outsourcing model

Monday, March 31, 2014 09:07 AM

Global CRO Parexel International has released Strategic Partnerships 2014: Driving Biopharmaceutical Outsourcing Effectiveness at the 23rd Annual Partnerships in Clinical Trials Conference in Las Vegas. It provides insights that highlight the value of these multi-year, highly integrated engagements between sponsors and CROs.

More... »

The Pulse on Technology By Ashley Tointon

Monday, March 31, 2014 09:00 AM

The development of apps for healthcare has reached an all-time high, with thousands currently available for multiple devices for both consumers and healthcare professionals. Global statistics show that downloads of mobile health (mHealth) apps almost doubled in less than a year, from 127 million in 2011 to 247 million by October 2012. With so many different apps available, reviewing all of the options and finding the right one can be daunting. As you sift through the vast array of apps, narrow your choice by assessing functionality, accessibility and cost.

More... »

Praziquantel Consortium aims to fight schistosomiasis in pre-schoolers

Friday, March 28, 2014 03:18 PM

Brazilian Farmanguinhos, part of Fiocruz, and U.K.-based Simcyp are reinforcing the international nonprofit Pediatric Praziquantel Consortium. The aim of the consortium is to develop and register a new pediatric formulation against schistosomiasis for preschool-age children, a group currently lacking a suitable treatment. 

More... »

Report: Nearly 40 new medicines in development for Parkinson’s disease

Friday, March 28, 2014 03:17 PM

America’s biopharmaceutical research companies currently are developing 37 innovative new medicines to help the estimated 10 million people worldwide living with Parkinson’s disease. These medicines in development, all either in clinical trials or under review by the FDA, include 23 for Parkinson’s disease, 11 for related conditions and three diagnostics, according to a new report by the Pharmaceutical Research and Manufacturers of America (PhRMA).

More... »

`
CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

April 14

Proposal calls for back-to-back trials to measure efficacy and effectiveness prior to FDA approval

Study: Minority populations under-represented in cancer trials, but have higher rates of incidence

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

April

Make way for mobile health in clinical trials
Despite patient retention, data quality benefits, regulatory hurdles persist

Global clinical trial laboratories decentralize
Regional labs reducing complexity, delivering cost and time savings

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

March

Strategic alliances hit bumps in the road
Mixed relationship performance driving new approaches

Tapping community hospitals for clinical trial volunteers
New study finds high potential but infrastructure, resources are lacking

Already a subscriber?
Log in to your digital subscription.

Purchase the March issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs